Reducing Hospital-Acquired Infections With Ultraviolet-C (UVC)

The financial consequences of hospital-acquired infections—reduced reimbursements, low patient-satisfaction scores, negative branding, litigation—never have been greater.

Hospital-acquired infections (HAIs) are a leading cause of death in the United States, killing more people than AIDS, breast cancer, and automobile accidents. In 2010 alone, HAIs contributed to more than 99,000 deaths—one death every 6 min—and costs of up to $57,000 per patient, with an increase in length of hospital stay of about 10 to 15 days.¹

The financial consequ

Register to view the full article

Register on HPAC.com and gain access to premium content, including this article and much more.

Already a member? .

Hide comments

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish